1. Cell cycle arrest induced by MPPa-PDT in MDA-MB-231 cells
   Liming Liang et al, 2016, Laser Physics CrossRef
2. 1,25(OH)2D3 induced apoptosis of human hepatocellular carcinoma cells in vitro and inhibited their growth in a nude mouse xenograft model by regulating histone deacetylase 2
   Jian Huang et al, 2018, Biochimie CrossRef
3. New insights into the role of vitamin D in hepatocellular carcinoma
   Dong-Bo Wu et al, 2018, Expert Review of Gastroenterology & Hepatology CrossRef
4. Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D
   Shahida Khan et al, 2018, Nutrition & Metabolism CrossRef
5. Antiproliferative activity of side-chain truncated vitamin D analogs (PRI-1203 and PRI-1204) against human malignant melanoma cell lines
   Anna Piotrowska et al, 2020, European Journal of Pharmacology CrossRef
6. Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system
   Mercedes Garcia‐Gil et al, 2017, British Journal of Pharmacology CrossRef
7. VİTAMİN D’NİN HEPATOSELÜLER KARSİNOM ÜZERİNDEKİ ETKİSİ
   Çağrı Öner et al, 2019, OSMANGAZİ JOURNAL OF MEDICINE CrossRef
8. Vitamin D and potential effects on cancers: a review
   Pouria Sobhi et al, 2024, Molecular Biology Reports CrossRef
9. Chemoprofiling and insilico prioritization of bioactive compounds from Laetiporus versisporus (Lloyd) Imazeki reveals potential Bcl-2 inhibitor
   Shoba G et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
10. II Consenso Mexicano de Carcinoma Hepatocelular. Parte I: Epidemiología y diagnóstico
    L.E. Cisneros-Garza et al, 2022, Revista de Gastroenterología de México CrossRef
11. Histone deacetylase 2 selective inhibitors: A versatile therapeutic strategy as next generation drug target in cancer therapy
    Manasa Gangadhar Shetty et al, 2021, Pharmacological Research CrossRef
12. Identifying potential pharmacological targets and mechanisms of vitamin D for hepatocellular carcinoma and COVID-19
    Yongbiao Huang et al, 2022, Frontiers in Immunology CrossRef
13. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies
    Takamasa Kobayashi et al, 2018, BMC Cancer CrossRef
14. Serum Bioavailable, Rather Than Total, 25‐hydroxyvitamin D Levels Are Associated With Hepatocellular Carcinoma Survival
    Ai‐Ping Fang et al, 2020, Hepatology CrossRef
15. The second Mexican consensus on hepatocellular carcinoma. Part I: Epidemiology and diagnosis
    L.E. Cisneros-Garza et al, 2022, Revista de Gastroenterología de México (English Edition) CrossRef
16. Vitamin D and K signaling pathways in hepatocellular carcinoma
    Manal L. Louka et al, 2017, Gene CrossRef
17. Vitamin D, inflammation, and cancer
    Enikö Kallay et al, 2024, Feldman and Pike's Vitamin D CrossRef
18. Vitamin D Inflammation and Cancer
    Enikö Kallay et al, 2018, Vitamin D CrossRef
19. The protective effect of 1,25(OH)2D3 against cardiac hypertrophy is mediated by the cyclin-dependent kinase inhibitor p21
    Ning Liu et al, 2020, European Journal of Pharmacology CrossRef
20. Inhibitory effects of 1,25(OH)2D3 on the proliferation of hepatocellular carcinoma cells through the downregulation of HDAC2
    Jian Huang et al, 2017, Oncology Reports CrossRef
21. Vitamin D receptor expression and potential role of vitamin D on cell proliferation and steroidogenesis in goat ovarian granulosa cells
    Xiaolei Yao et al, 2017, Theriogenology CrossRef
22. Vitamin D: Possible Therapeutic Roles in Hepatocellular Carcinoma
    Isaacson B. Adelani et al, 2021, Frontiers in Oncology CrossRef